Research · Randomized controlled trial
Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial
What it found
47.6% were ≥50% responders for attack frequency vs 14.4% placebo.
- Design
- Randomized controlled trial
- Year
- 2005
- Sample size
- 42
- Population
- adults with migraine
- Intervention
- coenzyme Q10 300 mg/day
- Outcome
- attack frequency
- Journal
- Neurology
Citation last checked 2026-06-21.